CVE-2017-12266

Description

A vulnerability in the routine that loads DLL files in Cisco Meeting App for Windows could allow an authenticated, local attacker to run an executable file with privileges equivalent to those of Cisco Meeting App. The vulnerability is due to incomplete input validation of the path name for DLL files before they are loaded. An attacker could exploit this vulnerability by installing a crafted DLL file in a specific system directory. A successful exploit could allow the attacker to execute commands on the underlying Microsoft Windows host with privileges equivalent to those of Cisco Meeting App. The attacker would need valid user credentials to exploit this vulnerability. Cisco Bug IDs: CSCvd77907.

Categories

4.2
CVSS
Severity: Medium
CVSS 3.0 •
CVSS 2.0 •
EPSS 0.03%
Vendor Advisory cisco.com
Affected: n/a Cisco Meeting App
Published at:
Updated at:

References

Frequently Asked Questions

What is the severity of CVE-2017-12266?
CVE-2017-12266 has been scored as a medium severity vulnerability.
How to fix CVE-2017-12266?
To fix CVE-2017-12266, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2017-12266 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2017-12266 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2017-12266?
CVE-2017-12266 affects n/a Cisco Meeting App.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.